NASDAQ:ACIU
AC Immune SA Stock News
$4.65
+0.680 (+17.13%)
At Close: May 31, 2024
Linde (LIN) to Report Q3 Earnings: What's in the Cards?
03:25pm, Friday, 08'th Nov 2019
Favorable industrial production in the United States is likely to have favored Linde's (LIN) Q3 earnings.
AC Immune Hosts Key Opinion Leader Event: ‘Untangling’ Tau Pathology to Treat Alzheimer’s and Neurodegenerative Diseases
09:05pm, Wednesday, 06'th Nov 2019
Company Provides Key Updates on Tau Pipeline Candidates LAUSANNE, Switzerland, Nov. 06, 2019 -- AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical-stage biopharmaceutical.
